MedTrace Logo

Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma

NCT00487773 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2010-04-13

No results posted yet for this study

Summary

The purpose of the trial is to check if inhaled glucocorticosteroids (iGCS) have influence on bone condition (if iGCS increases risk of osteoporosis and bone fraction) in children with asthma.

Conditions

Interventions

DRUG

budesonide

budesonide

DRUG

D3 vitamin

D3 vitamin

DRUG

montelukast sodium

montelukast sodium

DRUG

salbutamol

salbutamol

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Malgorzata Olszowiec-Chlebna, MD · Department of Pediatrics and Allergy, Medical University of Lodz, Poland

  • Iwona Stelmach, MD, PhD, Prof · Department of Pediatrics and Allergy, Medical University of Lodz, Poland

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00487773 on ClinicalTrials.gov